Avalo Therapeutics, Inc. (AVTX) Revenue 2016–2025
Avalo Therapeutics, Inc. (AVTX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$59,000FY2025 · since FY2016: $1.2M → $59,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $59,000 | -86.6% |
| FY2024 | $441,000 | -77.1% |
| FY2023 | $1.9M | -89.3% |
| FY2022 | $18.1M | +234.4% |
| FY2021 | $5.4M | -19.4% |
| FY2020 | $6.7M | -0.8% |
| FY2019 | $6.8M | -4.0% |
| FY2018 | $7.0M | -74.7% |
| FY2017 | $27.8M | +2312.3% |
| FY2016 | $1.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice